Literature DB >> 18004396

Emergence of spasmolytic polypeptide-expressing metaplasia in Mongolian gerbils infected with Helicobacter pylori.

Nao Yoshizawa1, Yoshiharu Takenaka, Hirokazu Yamaguchi, Tsukamoto Tetsuya, Harunari Tanaka, Masae Tatematsu, Sachiyo Nomura, James R Goldenring, Michio Kaminishi.   

Abstract

Spasmolytic polypeptide (TFF2)-expressing metaplasia (SPEM) is observed in mucosa adjacent to human gastric cancer and in fundic glands showing oxyntic atrophy in Helicobacter felis-infected mice. Mongolian gerbils infected with Helicobacter pylori (Hp) develop goblet cell intestinal metaplasia and adenocarcinoma, but the presence of SPEM has not been studied in gerbils. We therefore have sought to examine the development of metaplastic mucosal changes in Hp-infected Mongolian gerbils. Mongolian gerbils were assigned to either uninfected controls or infected with Hp at 17 weeks of age. The animals were killed at 17, 20, 26, 31, 41 and 56 weeks of age. Stomach sections were stained using antibodies for TFF2, intrinsic factor, H/K-ATPase, BrdU and MUC2. Dual immunofluorescence staining for TFF2 with intrinsic factor and for TFF2 with MUC2 was performed. In uninfected animals, no SPEM or intestinal metaplasia was observed. Infected gerbils developed SPEM initially in the intermediate zone along the lesser curvature and subsequently spread out towards the greater curvature. In the earlier stages of infection, SPEM glands demonstrated TFF2 and intrinsic factor double staining cells. However, after 35 weeks of infection, the number of double staining SPEM cells decreased. While early in infection SPEM organized in straight glands, in the later stages of infections, SPEM glands became distorted or dilated along with the development of gastritis cystica profunda that was TFF2 positive. Goblet cell intestinal metaplasia developed only late in the infection. Dual staining for TFF2 and MUC2 showed glands containing both SPEM- and MUC2-positive goblet cell intestinal metaplasia. SPEM develops early in Hp infection in Mongolian gerbils, and alterations in gland morphology arise from SPEM glands during the course of gastric infection with goblet cell intestinal metaplasia developing subsequent to SPEM.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18004396     DOI: 10.1038/labinvest.3700682

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  48 in total

1.  Spasmolytic polypeptide-expressing metaplasia and intestinal metaplasia: time for reevaluation of metaplasias and the origins of gastric cancer.

Authors:  James R Goldenring; Ki Taek Nam; Timothy C Wang; Jason C Mills; Nicholas A Wright
Journal:  Gastroenterology       Date:  2010-05-05       Impact factor: 22.682

Review 2.  Oxyntic atrophy, metaplasia, and gastric cancer.

Authors:  James R Goldenring; Ki Taek Nam
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

3.  Heterogeneity in mouse spasmolytic polypeptide-expressing metaplasia lineages identifies markers of metaplastic progression.

Authors:  Victoria G Weis; Josane F Sousa; Bonnie J LaFleur; Ki Taek Nam; Jared A Weis; Paul E Finke; Nadia A Ameen; James G Fox; James R Goldenring
Journal:  Gut       Date:  2012-07-07       Impact factor: 23.059

Review 4.  Stomach development, stem cells and disease.

Authors:  Tae-Hee Kim; Ramesh A Shivdasani
Journal:  Development       Date:  2016-02-15       Impact factor: 6.868

5.  MEK Inhibitor Reverses Metaplasia and Allows Re-Emergence of Normal Lineages in Helicobacter pylori-Infected Gerbils.

Authors:  Qing Yang; Tomohiko Yasuda; Eunyoung Choi; Takeshi Toyoda; Joseph T Roland; Eiji Uchida; Hiroshi Yoshida; Yasuyuki Seto; James R Goldenring; Sachiyo Nomura
Journal:  Gastroenterology       Date:  2018-11-02       Impact factor: 22.682

6.  A signalling cascade of IL-33 to IL-13 regulates metaplasia in the mouse stomach.

Authors:  Christine P Petersen; Anne R Meyer; Carlo De Salvo; Eunyoung Choi; Cameron Schlegel; Alec Petersen; Amy C Engevik; Nripesh Prasad; Shawn E Levy; R Stokes Peebles; Theresa T Pizarro; James R Goldenring
Journal:  Gut       Date:  2017-02-14       Impact factor: 23.059

7.  Cell lineage dynamics in the process leading to intestinal metaplasia.

Authors:  Hirotsugu Sakamoto; Hiroyuki Mutoh; Hiroko Hayakawa; Miho Sashikawa; Kentaro Sugano
Journal:  J Gastroenterol       Date:  2011-03-08       Impact factor: 7.527

8.  Maturity and age influence chief cell ability to transdifferentiate into metaplasia.

Authors:  Victoria G Weis; Christine P Petersen; Jared A Weis; Anne R Meyer; Eunyoung Choi; Jason C Mills; James R Goldenring
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-11-23       Impact factor: 4.052

9.  Amphiregulin-deficient mice develop spasmolytic polypeptide expressing metaplasia and intestinal metaplasia.

Authors:  Ki Taek Nam; Hyuk-Joon Lee; Hoyin Mok; Judith Romero-Gallo; James E Crowe; Richard M Peek; James R Goldenring
Journal:  Gastroenterology       Date:  2008-12-13       Impact factor: 22.682

10.  Targeted deletion of Kcne2 causes gastritis cystica profunda and gastric neoplasia.

Authors:  Torsten K Roepke; Kerry Purtell; Elizabeth C King; Krista M D La Perle; Daniel J Lerner; Geoffrey W Abbott
Journal:  PLoS One       Date:  2010-07-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.